IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMY LAUREN CUMMINGS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1043552243
CMS profile
8425592
Location
TORRANCE, CA

General Payments · PY2020–2024

$103,353.21

  • Reported across 69 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$95,787.92

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Grant $50,000.00 1
Consulting Fee $35,178.75 15
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,200.00 3
Travel and Lodging $3,115.02 10
Food and Beverage $1,294.15 19

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $50,000.00 1
Acerta Pharma LLC $23,245.33 20
TAIHO ONCOLOGY, INC. $6,389.95 7
E.R. Squibb & Sons, L.L.C. $6,377.06 5
Tempus AI, Inc $3,512.25 5
Genmab U.S., Inc. $2,171.58 2
Daiichi Sankyo Inc. $2,055.00 2
PFIZER INC. $1,000.00 1
Boehringer Ingelheim Pharmaceuticals, Inc. $937.84 3
NOVARTIS PHARMACEUTICALS CORPORATION $52.42 1
Genentech USA, Inc. $46.49 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $994.36 5
PY2022 $320.92 10
PY2023 $6,250.01 6
PY2024 $95,787.92 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $2,740.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1104715967 CMS
AstraZeneca Pharmaceuticals LP $45.26 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104341616 CMS
AstraZeneca Pharmaceuticals LP $22.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104369647 CMS
AstraZeneca Pharmaceuticals LP $52.39 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104740573 CMS
AstraZeneca Pharmaceuticals LP $80.18 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105264207 CMS
AstraZeneca Pharmaceuticals LP $598.78 02/21/2024 Travel and Lodging Undisputed 01/23/2026 1105645220 CMS
AstraZeneca Pharmaceuticals LP $49.25 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105669385 CMS
AstraZeneca Pharmaceuticals LP $51.02 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104223269 CMS
AstraZeneca Pharmaceuticals LP $2,740.00 03/05/2024 Consulting Fee Undisputed 01/23/2026 1105524299 CMS
AstraZeneca Pharmaceuticals LP $135.00 06/03/2024 Food and Beverage Undisputed 01/23/2026 1104407829 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1104555164 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/05/2024 Consulting Fee Undisputed 01/23/2026 1105599259 CMS
AstraZeneca Pharmaceuticals LP $59.84 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104245687 CMS
AstraZeneca Pharmaceuticals LP $390.49 08/19/2024 Travel and Lodging Undisputed 01/23/2026 1104646673 CMS
AstraZeneca Pharmaceuticals LP $142.06 08/19/2024 Travel and Lodging Undisputed 01/23/2026 1105599433 CMS
AstraZeneca Pharmaceuticals LP $121.66 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104252749 CMS
AstraZeneca Pharmaceuticals LP $74.92 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105680927 CMS
AstraZeneca Pharmaceuticals LP $6,560.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 1105751041 CMS
AstraZeneca Pharmaceuticals LP $5,137.50 12/16/2024 Consulting Fee Undisputed 01/23/2026 1105443159 CMS
AstraZeneca Pharmaceuticals LP $134.81 12/20/2024 Food and Beverage Undisputed 01/23/2026 1104495960 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $666.39 11/25/2024 Travel and Lodging Undisputed 01/23/2026 1117850215 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $87.15 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1117850211 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $184.30 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1117850213 CMS
Daiichi Sankyo Inc. $342.50 07/10/2024 Consulting Fee Undisputed 01/23/2026 1089412172 CMS
Daiichi Sankyo Inc. $1,712.50 07/10/2024 Consulting Fee Undisputed 01/23/2026 1089412174 CMS
E.R. Squibb & Sons, L.L.C. $65.00 07/27/2024 Food and Beverage Undisputed 01/23/2026 1101436317 CMS
E.R. Squibb & Sons, L.L.C. $22.06 07/27/2024 Food and Beverage Undisputed 01/23/2026 1101436361 CMS
E.R. Squibb & Sons, L.L.C. $3,840.00 08/13/2024 Consulting Fee Undisputed 01/23/2026 1101436269 CMS
E.R. Squibb & Sons, L.L.C. $50.00 09/08/2024 Food and Beverage Undisputed 01/23/2026 1101436357 CMS
E.R. Squibb & Sons, L.L.C. $2,400.00 09/16/2024 Consulting Fee Undisputed 01/23/2026 1101436275 CMS
Genentech USA, Inc. $46.49 06/02/2024 Food and Beverage Undisputed 01/23/2026 1132975735 CMS
Genmab U.S., Inc. $2,096.25 09/03/2024 Consulting Fee Undisputed 01/23/2026 1126824156 CMS
Genmab U.S., Inc. $75.33 09/03/2024 Food and Beverage Undisputed 01/23/2026 1126824158 CMS
Merck Sharp & Dohme LLC $50,000.00 03/25/2024 Grant Undisputed 01/23/2026 1141897974 CMS
Novartis Pharmaceuticals Corporation $52.42 02/23/2024 Food and Beverage Undisputed 01/23/2026 1086616583 CMS
PFIZER INC. $1,000.00 09/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132011152 CMS
TAIHO ONCOLOGY, INC. $651.95 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1137940986 CMS
TAIHO ONCOLOGY, INC. $75.40 09/30/2024 Travel and Lodging Undisputed 01/23/2026 1137934891 CMS
TAIHO ONCOLOGY, INC. $144.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 1137934895 CMS
TAIHO ONCOLOGY, INC. $3,000.00 09/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137940228 CMS
TAIHO ONCOLOGY, INC. $2,200.00 10/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137934893 CMS
TAIHO ONCOLOGY, INC. $66.60 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1137941662 CMS
TAIHO ONCOLOGY, INC. $251.90 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1137943839 CMS
Tempus AI, Inc $1,125.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1150163160 CMS
Tempus AI, Inc $1,125.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1150163162 CMS
Tempus AI, Inc $500.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1150163164 CMS
Tempus AI, Inc $12.25 04/19/2024 Food and Beverage Undisputed 01/23/2026 1150163166 CMS
Tempus AI, Inc $750.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1150163168 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.